Control of scabies and secondary impetigo: optimising treatment effectiveness in endemic settings

Lancet Infect Dis. 2019 May;19(5):454-456. doi: 10.1016/S1473-3099(19)30068-4. Epub 2019 Apr 4.

Authors

Olivier Chosidow¹, Roderick J Hay²

Affiliations

¹ Department of Dermatology, Hôpital Henri-Mondor, AP-HP, Université Paris-Est Créteil Val-de-Marne, Créteil, 94010, France. Electronic address: olivier.chosidow@aphp.fr.
² St Johns Institute of Dermatology, Kings College London, London, UK.

PMID: 30956112
DOI: 10.1016/S1473-3099(19)30068-4

No abstract available

Publication types

Comment

MeSH terms

Azithromycin
Humans
Impetigo*
Ivermectin
Mass Drug Administration
Scabies*
Treatment Outcome

Substances

Ivermectin
Azithromycin